Patents Assigned to The University
  • Patent number: 8715523
    Abstract: There is provided a heat storage material capable of recovering/storing thermal energy such as exhaust heat energy or sunlight, and a heat utilization system using the same. The heat storage material of the present invention comprises a complex compound of the formula (I), wherein, R, R?, A, B, C, D, A?, B?, C? and D? are as defined herein.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: May 6, 2014
    Assignees: The University of Tokyo, Denso Corporation
    Inventors: Hirohiko Houjou, Hajime Shingai, Katsunori Iwase
  • Patent number: 8716688
    Abstract: An electronic device includes a first electrode, a second electrode and a nanowire connected between the first and second electrodes to allow electric current flow. The nanowire is made from a conductive material exhibiting a variable resistance due to electromigration. The nanowire is repeatably switchable between two states. A voltage clamp operates through feedback control to maintain the voltage across the nanowire and prevent thermal runaway.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: May 6, 2014
    Assignee: The University of Kentucky Research Foundation
    Inventors: Douglas R. Strachan, Stephen L. Johnson
  • Patent number: 8718734
    Abstract: A noninvasive polarimetric apparatus used to measure levels of a substance in a sample in the presence of dynamically changing sample birefringence is provided. A polarization system generates multiple states of polarized light which interact with the sample. An analyzer system receives a signal from the sample and generates a secondary signal. This signal is detected and then processed to measure levels of a substance in a sample that may be have time varying birefringent components.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: May 6, 2014
    Assignee: The University of Toledo
    Inventor: Brent D. Cameron
  • Patent number: 8716595
    Abstract: High performance photovoltaic devices are provided. Certain embodiments relate to the use of Boron-Nitride (BN) thin films as anti-reflection coating (ARC) material on Si and GaAs solar cells. A low and wide reflectance window covering a large energy range of the solar spectrum is available. For a large part of the useful solar spectrum, the index of refraction of the grown BN thin films remains constant at about 2.8. In another embodiment, a BN ARC is applied directly on ordinary window glass providing the device's mechanical strength.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: May 6, 2014
    Assignee: The University of Houston
    Inventors: Nacer Badi, Alex Freundlich, Abdelhak Bensaoula, Andenet Alemu
  • Patent number: 8718411
    Abstract: A method and apparatus for providing optical supercontinuum. The method comprises creating a spectrally narrow phase feature within a supercontinuum spectrum produced from a laser pulse that has been subjected to supercontinuum generation, thereby producing a modified supercontinuum spectrum, and propagating the modified supercontinuum spectrum through an optical waveguide that is suitable for supercontinuum generation, thereby further modifying the modified supercontinuum spectrum. The method may include modifying the modified supercontinuum spectrum by increasing its energy in a vicinity of the phase feature.
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: May 6, 2014
    Assignee: The University of Sydney
    Inventors: Dane Austin, Benjamin John Eggleton, Carel Martijn De Sterke, Paul Steinvurzel, Jeremy Bolger, Thomas Brown, Feng Luan, Dong-Il Yeom
  • Patent number: 8716258
    Abstract: The present invention provides a method of regulating fatty acid metabolism in a cell by contacting the cell with a modulator of miR-378 and/or miR-378* activity or expression. The present invention also provides a method of treating or preventing a metabolic disorder, such as obesity, diabetes, or metabolic syndrome, in a subject by administering to the subject an inhibitor of miR-378 and/or miR-378* expression or activity. Methods of treating or preventing pathologic cardiac hypertrophy, cardiac remodeling, myocardial infarction, or heart failure in a subject by inhibiting the expression or activity of miR-378 and/or miR-378* in a subject are also disclosed.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: May 6, 2014
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Eric N. Olson, Michele Carrer
  • Patent number: 8715680
    Abstract: The invention provides polypeptides derived from a major histocompatibility complex (MHC) class I human leukocyte antigen (HLA), such as HLA-A2, and derivatives or analogues thereof. The polypeptides, derivatives and analogues can be used to treat or prevent allosensitisation, such as the treatment or prevention of allograft rejection.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: May 6, 2014
    Assignee: The University of Birmingham
    Inventors: Simon Ball, Bernard Maillere
  • Patent number: 8716457
    Abstract: The present invention provides modified nucleobase compounds, modified nucleic acid mimetic compounds and various uses thereof. In addition, the invention provides methods for nucleobase characterisation, SNP characterisation and nucleic acid sequencing.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: May 6, 2014
    Assignee: The University Court of the University of Edinburgh
    Inventors: Mark Bradley, Juan J. Diaz-Mochon
  • Patent number: 8716307
    Abstract: The present invention is directed to methods of using a sirolimus drug and chloroquine or a quinoline derivative in combination. Methods of use are also described.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: May 6, 2014
    Assignee: The Trustees Of The University of Pennsylvania
    Inventors: Ravi Kumar Amaravadi, Craig B. Thompson
  • Patent number: 8716836
    Abstract: A high-quality GaAs-type crystal thin film using an inexpensive Si wafer with good thermal release characteristics is achieved. Provided is a semiconductor wafer comprising an Si wafer; an inhibiting layer that is formed on the wafer and that inhibits crystal growth, the inhibiting layer including a covering region that covers a portion of the wafer and an open region that does not cover a portion of the wafer within the covering region; a Ge layer that is crystal-grown in the open region; and a functional layer that is crystal-grown on the Ge layer. The Ge layer may be formed by annealing with a temperature and duration that enables movement of crystal defects, and the annealing is repeated a plurality of times.
    Type: Grant
    Filed: December 26, 2008
    Date of Patent: May 6, 2014
    Assignees: Sumitomo Chemical Company, Limited, The University of Tokyo
    Inventors: Tomoyuki Takada, Sadanori Yamanaka, Masahiko Hata, Taketsugu Yamamoto, Kazumi Wada
  • Publication number: 20140118592
    Abstract: A CMOS imaging sensor with ernbedded feature extraction capability operatable in different modes by a method that includes the steps of: (a) operating the CMOS imaging sensor in a motion-detecting mode at a first power level using circuitry on the imaging sensor that generates motion data based on received images detected by pixels in the pixel array; (b) switching the imaging sensor from the motion-detecting mode to a feature extraction mode in response to detecting motion; and (c) operating the imaging sensor in the feature extraction mode at a second power level that is higher than the first power level.
    Type: Application
    Filed: October 28, 2013
    Publication date: May 1, 2014
    Applicant: The Regents of The University of Michigan
    Inventors: Euisik Yoon, Jaehyuk Choi
  • Publication number: 20140121511
    Abstract: Systems and methods which utilize stress first and then rest imaging techniques to provide for improved medical imaging results are provided herein. One embodiment may administer a stress regime, such as exercise stress, and administer a tracer to a patient and retrieve a stress image. Then a second tracer is administered to a patient and a resting image is retrieved. Embodiments may implement this method with PET/CT scanning techniques. Additionally, embodiments may utilize a single CT scan when obtaining both the stress and rest images.
    Type: Application
    Filed: October 30, 2012
    Publication date: May 1, 2014
    Applicants: The University of Utah Research Foundation
    Inventor: The University of Utah Research Foundation
  • Publication number: 20140120139
    Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.
    Type: Application
    Filed: January 25, 2013
    Publication date: May 1, 2014
    Applicant: Board of Regents, The University of Texas System
    Inventors: Maria A. Croyle, Jin Huk Choi, Stephen Schafer
  • Publication number: 20140118150
    Abstract: A system (10) and method for use by a subject with a sleep disorder, such as nocturnal enuresis. The system (10) comprises at least one sensor (11) that detects at least one attribute of the sleep disorder, for example urine, and outputs at least a first signal on or after detection of that attribute. The system (10) further comprises a control device (12) that comprises an arousal device (14), such as a loudspeaker, that activates on or after receipt of the first signal, an interactive device (15) that is actuable by the subject to deactivate or modify the operation of the arousal device (14) and an output device (16) for delivering an output to the subject. The output being delivered on or after deactivation or modification of the arousal device (14).
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicants: The University of Sydney, The Sydney Children's Hospitals Network (Randwick and Westmead)
    Inventors: Patrina Ha Yuen Caldwell, Michael Lance Dickinson, James Charles Kerr McCauley, Geoffrey Gordon Wickham
  • Publication number: 20140119496
    Abstract: The present subject matter relates to compact, non-synchrotron microbeam radiation therapy (MRT) systems and methods for cancer research and treatment based on a carbon nanotube distributed x-ray source array technology. The systems and methods can deliver microscopically discrete x-ray radiation at peak dose rate of 10 Gy per second or higher. The x-ray radiation can be provided by a spatially distributed x-ray source array. The technology can be used, for example and without limitation, for human cancer treatment, for intra-operative radiation therapy, and for pre-clinical cancer research on animal cancer models.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 1, 2014
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Otto Z. ZHOU, Sha X. CHANG
  • Patent number: 8711961
    Abstract: Techniques are generally described here for communicating channel state information using predictive vector quantization. In some examples, a method may include measuring channel state information based, at least in part, on signals received over a communications channel. An error vector may be calculated between the measured channel state information and predicted channel state information. The error vector may be quantized, and subsequent channel state information may be predicted based, at least in part, on the quantized error vector.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: April 29, 2014
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Robert W. Heath, Jr., Takao Inoue
  • Patent number: 8710020
    Abstract: A method for providing antisense therapy which reduces the expression of clusterin to provide therapeutic benefits in the treatment of cancer comprising administering from 40 to 640 mg anti-clusterin antisense oligonucleotide to a patient in need of treatment for a cancer expressing clusterin is provided. The method may include administering chemotherapeutic agent or agents, radiotherapy, and/or hormone ablation therapy. The invention also encompasses pharmaceutical compositions formulated to provide a dosage of 40 to 640 mg, and use of antisense in formulating a medicament.
    Type: Grant
    Filed: April 4, 2005
    Date of Patent: April 29, 2014
    Assignee: The University of British Columbia
    Inventors: Martin E. Gleave, Scott D. Cormack
  • Patent number: 8709127
    Abstract: Platinum particles have been formed as porous, hollow tubular dendrites by using silver dendrite particles in a galvanic replacement reaction conducted in an aqueous solution of a platinum compound. The dendritic platinum particles have been found useful as catalysts and particularly useful as a hydrogen-oxidation electrocatalyst and/or an oxygen-reduction catalyst in a polymer electrolyte membrane fuel cell.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: April 29, 2014
    Assignees: GM Global Technology Operations LLC, The University of Western Ontario
    Inventors: Mei Cai, Xueliang Sun, Gaixia Zhang, Shuhui Sun, Ruying Li
  • Patent number: 8709821
    Abstract: The present invention relates to a compound having a structure analogous to firefly luciferin. In particular, the invention relates to a heterocycle compound which produces a luminescence at a light wavelength different from that of firefly luciferin in nature. The present invention provides a heterocycle compound of following general formula I. In the above general formula, R1, R2 and R3 can be each independently H or C1-4-alkyl. In the above general formula, X and Y can be each independently C, N, S or O. In the above general formula, the olefin chain part expressed as ā€œnā€ can be changed to desired length.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: April 29, 2014
    Assignees: The University of Electro-Communications, Campus Create Co., Ltd.
    Inventors: Shojiro Maki, Satoshi Kojima, Haruki Niwa
  • Patent number: 8709342
    Abstract: The present invention provides antimicrobial solutions that comprise at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant. Also provided are methods for rapidly reducing a microbe or a virus from surfaces including surfaces of indwelling medical devices and organic surfaces such as skin and sutures, and inorganic surfaces such as hospital equipment, pipelines etc.
    Type: Grant
    Filed: September 17, 2012
    Date of Patent: April 29, 2014
    Assignee: Board of Regents, The University of Texas System
    Inventor: Issam Raad